These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 8851847

  • 1. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA, Bokemeyer C, Serth J, Machtens S, Höfner K, Jonas U.
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [Abstract] [Full Text] [Related]

  • 2. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Jan; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.
    Sogani PC.
    Urol Clin North Am; 1991 Aug; 18(3):561-73. PubMed ID: 1652171
    [Abstract] [Full Text] [Related]

  • 4. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW.
    Cancer; 1998 Sep 01; 83(5):1002-11. PubMed ID: 9731905
    [Abstract] [Full Text] [Related]

  • 5. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP.
    Hematol Oncol Clin North Am; 1991 Dec 01; 5(6):1127-42. PubMed ID: 1663937
    [Abstract] [Full Text] [Related]

  • 6. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct 01; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 7. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A, Pfister D.
    Arch Esp Urol; 2012 Mar 01; 65(2):215-26. PubMed ID: 22414450
    [Abstract] [Full Text] [Related]

  • 8. [New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
    Albers P, Ulbright TM, Albers J, Miller GA, Foster RS, Donohue JP.
    Urologe A; 1995 Jul 01; 34(4):316-23. PubMed ID: 7676541
    [Abstract] [Full Text] [Related]

  • 9. [Risk-guided after-care of testicular tumor].
    Schölermann KH, Dettmann R, Hartmann M.
    Urologe A; 1996 Jul 01; 35(4):326-30. PubMed ID: 8928363
    [Abstract] [Full Text] [Related]

  • 10. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D, Farmakis D, Pectasides M.
    Oncology; 2006 Jul 01; 71(3-4):151-8. PubMed ID: 17646698
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    BJU Int; 2007 May 01; 99(5):993-7. PubMed ID: 17437432
    [Abstract] [Full Text] [Related]

  • 12. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D, Pectasides E, Constantinidou A, Aravantinos G.
    Crit Rev Oncol Hematol; 2009 May 01; 70(2):114-23. PubMed ID: 18805019
    [Abstract] [Full Text] [Related]

  • 13. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
    Sparwasser C, Treiber U, Beckert R, Pust RA.
    Urologe A; 1995 Nov 01; 34(6):444-8. PubMed ID: 8848854
    [Abstract] [Full Text] [Related]

  • 14. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J.
    J Urol; 2005 Aug 01; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [Abstract] [Full Text] [Related]

  • 15. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P, Haas RJ, Göbel U, Calaminus G.
    Klin Padiatr; 2002 Aug 01; 214(4):167-72. PubMed ID: 12165897
    [Abstract] [Full Text] [Related]

  • 16. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T, Goepel M, Seeber S, Rübben H.
    Urologe A; 1993 May 01; 32(3):189-93. PubMed ID: 7685554
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1993 May 01; 205(4):225-30. PubMed ID: 8397320
    [Abstract] [Full Text] [Related]

  • 18. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Klein EA.
    BJU Int; 2009 Nov 01; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [Abstract] [Full Text] [Related]

  • 19. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB, McDermott DW, Dock W, Bahnson E, Berry AM, Steele GS, Richie JP.
    J Urol; 2009 May 01; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [Abstract] [Full Text] [Related]

  • 20. [Is lymphadenectomy in stage I of non-seminomatous testicular cancer still justified?].
    Höltl W, Kosak D, Pont J, Hruby W.
    Wien Klin Wochenschr; 1987 Jan 23; 99(2):60-3. PubMed ID: 3564488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.